ATC code none PubChem CID 10052040 UNII J8211Y53EF Molar mass 510.4 g/mol | CAS Number 686344-29-6 ChemSpider 8227602 KEGG D09362 | |
 | ||
Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesity, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.
References
Otenabant Wikipedia(Text) CC BY-SA